Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medallion›
Analysis
AddedFeb 15, 2024
UpdatedJun 26, 2026
Medallion

Medallion

Series D

Medallion is an AI-powered credentialing and enrollment platform that streamlines healthcare provider network management.

HQ
San Francisco, CA, US
Founded
2020
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Contents

  1. 01Executive Summary
  2. 02Products & Services
  3. 03Market Outlook
  4. 04Competitive Strengths
  5. 05Competitive Risks
  1. 01Executive Summary
  2. 02Products & Services
  3. 03Market Outlook
  4. 04Competitive Strengths
  5. 05Competitive Risks

Memo

Medallion is an AI-powered credentialing and enrollment platform designed to streamline healthcare provider network management. The company combines purpose-built AI agents with expert oversight to deliver end-to-end outcomes for credentialing, privileging, payer enrollment, roster management, and monitoring, backed by contract-backed performance guarantees. Its platform serves approximately one million clinicians across more than 300 healthcare organizations, reducing onboarding times from days to under two hours.

Founded in 2020 and headquartered in San Francisco, Medallion has raised 130 million dollars in total funding from investors including Sequoia Capital, Google Ventures, Acrew Capital, Optum Ventures, and Salesforce Ventures. The company recently launched CredAlliance, a national credentialing clearinghouse intended to eliminate redundant credentialing checks across participating payer networks, and expanded its privileging capabilities to align with Joint Commission standards.

Product Overview

Medallion offers an AI-powered platform for healthcare credentialing and enrollment operations. The platform includes seven core solutions: Provider Enrollment, CVO Credentialing, Roster Management, Delegated Credentialing, Privileging, Cross-State Licensing, and Monitoring. Each solution uses AI agents combined with expert oversight to deliver outcomes backed by performance guarantees.

The platform serves approximately one million clinicians across more than 300 healthcare organizations, reducing onboarding times from days to under two hours. Medallion recently launched CredAlliance, a national credentialing clearinghouse designed to eliminate redundant verification across payer networks.

Market Outlook

Medallion operates in the growing healthcare credentialing market, which is estimated to cost the industry over one billion dollars annually in redundant verification processes. The provider shortage and credentialing bottlenecks are significant challenges facing healthcare today, creating strong demand for automated solutions.

The company is well-positioned to capture this opportunity through its AI-powered platform that reduces onboarding from days to hours, its CredAlliance clearinghouse initiative that eliminates redundant payer verification, and its contract-backed performance guarantees that differentiate it from traditional credentialing services.

Competitive Advantages

Medallion differentiates through its AI agent workforce combined with expert-in-the-loop oversight, ensuring both speed and accuracy. The platform offers real-time credentialing capabilities, delivering NCQA-compliant files in as little as one day. The company provides contract-backed SLA guarantees, with a command and control center for complete operational visibility.

Medallion also operates a proprietary payer clearinghouse, enabling faster provider enrollment. The launch of CredAlliance creates a first-of-its-kind shared credentialing infrastructure for payers, designed to eliminate redundant verification processes that cost the industry an estimated 1.2 billion dollars annually. The company serves approximately one million clinicians, representing about 10 percent of the U.S. healthcare workforce.

Competitive Disadvantages

Medallion operates in a competitive healthcare credentialing market dominated by established enterprise players like symplr, which serves 9 of 10 U.S. hospitals and has decades of installed-base relationships. The credentialing industry has high switching costs and long sales cycles, making it difficult for newer entrants to displace entrenched incumbents.

Additionally, the platform's heavy reliance on AI automation may face resistance from healthcare organizations that prefer traditional manual oversight for compliance-sensitive credentialing processes. Regulatory complexity across states and payers creates ongoing product development challenges, and the company's success depends on maintaining accuracy and trust as it scales to serve an even larger portion of the U.S. healthcare workforce.